Radiolabelling of nanomaterials for medical imaging and therapy
Nanomaterials offer unique physical, chemical and biological properties of interest for
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
Molecular imaging in primary staging of prostate cancer patients: current aspects and future trends
R Manafi-Farid, S Ranjbar, Z Jamshidi Araghi, J Pilz… - Cancers, 2021 - mdpi.com
Simple Summary Accurate primary staging for determining the extent of prostate cancer is
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …
Molecular imaging of angiogenesis in oncology: current preclinical and clinical status
A Florea, FM Mottaghy, M Bauwens - International journal of molecular …, 2021 - mdpi.com
Angiogenesis is an active process, regulating new vessel growth, and is crucial for the
survival and growth of tumours next to other complex factors in the tumour …
survival and growth of tumours next to other complex factors in the tumour …
Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
Abstract Purpose:(4S)-4-(3-[18F] Fluoropropyl)-L-glutamic acid (18F-FSPG) is a
radiopharmaceutical for PET imaging of system xC− activity, which can be upregulated in …
radiopharmaceutical for PET imaging of system xC− activity, which can be upregulated in …
Preclinical imaging of prostate cancer
C Olkowski, B Fernandes, GL Griffiths, F Lin… - Seminars in Nuclear …, 2023 - Elsevier
Prostate cancer remains a major cause of mortality and morbidity, affecting millions of men,
with a large percentage expected to develop the disease as they reach advanced ages …
with a large percentage expected to develop the disease as they reach advanced ages …
New frontiers in molecular imaging using peptide-based radiopharmaceuticals for prostate cancer
X Li, H Cai, X Wu, L Li, H Wu, R Tian - Frontiers in Chemistry, 2020 - frontiersin.org
The high incidence of prostate cancer (PCa) increases the need for progress in its
diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for …
diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for …
Modular one-pot strategy for the synthesis of heterobivalent tracers
T Bailly, S Bodin, V Goncalves, F Denat… - ACS Medicinal …, 2023 - ACS Publications
Bivalent ligands, ie, molecules having two ligands covalently connected by a linker, have
been gathering attention since the first description of their pharmacological potential in the …
been gathering attention since the first description of their pharmacological potential in the …
Prognostic and theranostic applications of positron emission tomography for a personalized approach to metastatic castration-resistant prostate cancer
L Filippi, V Frantellizzi, A Chiaravalloti… - International Journal of …, 2021 - mdpi.com
Metastatic castration-resistant prostate cancer (mCRPC) represents a condition of
progressive disease in spite of androgen deprivation therapy (ADT), with a broad spectrum …
progressive disease in spite of androgen deprivation therapy (ADT), with a broad spectrum …
Clinical advancement of precision theranostics in prostate cancer
Theranostic approaches with positron emission tomography/computed tomography
(PET/CT) or PET/magnetic resonance imaging (PET/MRI) molecular imaging probes are …
(PET/CT) or PET/magnetic resonance imaging (PET/MRI) molecular imaging probes are …
[HTML][HTML] Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers
N Bertrand, R Mougel, G Riley, M Bruand… - International Journal of …, 2024 - mdpi.com
Neurotensin (NT) is a peptide involved in digestion, neuromodulation, and cancer
progression. NT and its receptors (NTR1 and SORT1 mainly) have been widely studied in …
progression. NT and its receptors (NTR1 and SORT1 mainly) have been widely studied in …